Jump to content

DSM IP ASSETS B.V. (20240263172). CRISPR TRANSIENT EXPRESSION CONSTRUCT (CTEC) simplified abstract

From WikiPatents

CRISPR TRANSIENT EXPRESSION CONSTRUCT (CTEC)

Organization Name

DSM IP ASSETS B.V.

Inventor(s)

Johannes Andries Roubos of Echt (NL)

Rene Verwaal of Echt (NL)

Brenda Vonk of Echt (NL)

CRISPR TRANSIENT EXPRESSION CONSTRUCT (CTEC) - A simplified explanation of the abstract

This abstract first appeared for US patent application 20240263172 titled 'CRISPR TRANSIENT EXPRESSION CONSTRUCT (CTEC)

Simplified Explanation: The patent application relates to a CRISPR transient expression construct (CTEC) for a genome editing system in the fields of molecular biology and cell biology.

Key Features and Innovation:

  • CRISPR transient expression construct (CTEC) for genome editing
  • Specific application in molecular biology and cell biology
  • Enhances precision and efficiency of genome editing systems

Potential Applications: The technology can be used in research laboratories, biotechnology companies, and pharmaceutical industries for precise genome editing in various organisms.

Problems Solved: The technology addresses the challenges of achieving precise and efficient genome editing in molecular and cell biology research.

Benefits:

  • Improved precision and efficiency in genome editing
  • Potential for breakthrough discoveries in genetic research
  • Enhanced capabilities for gene therapy and biotechnology applications

Commercial Applications: The CRISPR transient expression construct (CTEC) has significant commercial potential in the biotechnology and pharmaceutical industries for developing novel therapies and products.

Questions about CRISPR Transient Expression Construct (CTEC): 1. How does the CTEC technology improve genome editing efficiency? 2. What are the potential limitations of using CTEC in genome editing applications?


Original Abstract Submitted

the present invention relates to the field of molecular biology and cell biology. more specifically, the present invention relates to a crispr transient expression construct (ctec) for a genome editing system.

(Ad) Transform your business with AI in minutes, not months

Custom AI strategy tailored to your specific industry needs
Step-by-step implementation with measurable ROI
5-minute setup that requires zero technical skills
Get your AI playbook

Trusted by 1,000+ companies worldwide

Cookies help us deliver our services. By using our services, you agree to our use of cookies.